More about Sun Pharmaceutical Industries Limited
Fundamentals for Sun Pharmaceutical Industries Limited
Regulatory Filings for Sun Pharmaceutical Industries Limited
IndiGo Implements Steep Fuel Surcharge as Iran Conflict Sends Jet Fuel Costs Soaring
The RBI's New Forex Fortress: Defensive Maneuvers in an Era of Oil Shocks
India's Fiscal Milestone: GST Collections Breach ₹2 Lakh Crore Mark for the First Time
AI Disruption Accelerates: Oracle Layoffs Raise Alarms for India’s Tech Workforce
Technicals for Sun Pharmaceutical Industries Limited
Price Summary
Sun Pharmaceutical Industries Limited's stock opened at 1702.7 on 2026-04-09, surged to a high of 1730.9, hit a low of 1702.7, and closed up 0.85% at 1717.1, with 3276108 shares traded.The stock's highest price over the 52-week span is 1841.6, while the lowest price is 0.0.
Analysts expect the price of SUNPHARMA to vary between 1575.0 and 2450.0, with an average expected price near 1965.2894.
Technicals
Support and Resistance: The price for SUNPHARMA at 1717.1 finds support at 1675.4 and resistance at 1745.9. This suggests a trading range, where 1675.4 serves as a support level and 1745.9 acts as a resistance point, potentially capping further gains.Aroon: The current reading of the AROON is neutral for SUNPHARMA, with no clear signals for an upward or downward trend. This indicates that the market may be in a state of uncertainty, with no dominant force driving the direction.
Bol. Bands: The BOLL BANDS is currently neutral, showing no clear bias toward a rising or falling trend. This lack of directional clarity suggests that the market may be in a holding pattern, awaiting further developments.
Parabolic SAR: The PSAR continues its bearish outlook, setting a key resistance level that could limit upward potential. This resistance suggests that the market may struggle to break higher, reflecting ongoing bearish pressure for SUNPHARMA.
Stochastic: The current reading of the STOCHASTIC is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
Tripple Moving Agerage: The Tripple MOVING AVG is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
Before diving into the technical aspects of a company, such as stock price charts or volume trends, it's important to understand its fundamentals. These fundamentals include financial stability, growth potential, and strategic positioning. Additionally, knowing the broader industry landscape, including competitive pressures and regulatory factors, offers deeper insights. When this fundamental analysis is combined with technical indicators, it leads to more informed, accurate evaluations of the company's overall performance.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
U.S. Labor Market in 2026: JOLTS and Consumer Confidence Reveal Why Hiring Cooled Without Unemployment Spike
Lending Unleashed: Assessing the Impact of the Federal Reserve’s Capital Rollback
Calendar Collision: How Mahavir Jayanti's Overlap With Fiscal Year-End Reshapes India's Tax-Loss Harvesting Landscape